News

Promising New Drug Development Could Help Treat Cachexia

Researchers seeking canine candidates for a pilot study testing drugs to treat the wasting disease often associated with cancer

 


ResearcherSandra Bechtel in partnership with Tensive Controls, Inc. has developed a drug that could reverse cachexia. The team currently is seeking canine candidates for a pilot study to test the new drug.

Sandra Bechtel in partnership with Tensive Controls, Inc. has developed a drug that could reverse cachexia. The team currently is seeking canine candidates for a pilot study to test the new drug.
Download photo from the MU News Bureau

Story posted: April 17, 2017

By: Jeff Sossamon

Contact: Tracey Berry, Director of Communications, College of Veterinary Medicine,  573-884-2215, berryt@missouri.edu

By Molly Peterson

COLUMBIA, Mo. – According to the National Cancer Institute, nearly one-third of cancer deaths can be attributed to a wasting syndrome known as cachexia. Cachexia, an indicator of the advanced stages of disease, is a debilitating disorder that causes loss of appetite, lean body mass and can lead to multi-organ failure. Now, researchers at the University of Missouri in partnership with Tensive Controls, Inc. have developed a drug that could reverse cachexia. The team currently is seeking canine candidates for a pilot study to test the new drug.